The United States will commit $1 billion toward the purchase of ingredients for a swine flu vaccine, Washington's top health official said as US deaths from the virus continued to mount.
"There will be another $1 billion worth of orders placed to get the bulk ingredients for an H1N1 vaccination," Health and Human Services Secretary Kathleen Sebelius told CNN television yesterday, adding that the final vaccine likely will be ready by October.
"Congress has agreed with the president that this is the number one priority, keeping Americans safe and secure," she said, adding that US scientists are working "to get the shots in folks' arms."
Her remarks came as the Centers for Disease Control and Prevention confirmed 211 US deaths from the A(H1N1) virus, with some 37,000 cases confirmed — the highest level of death and infection of any country in the world.
Officials have warned that the virus could return with a vengeance in the the coming months. The virus, already deemed at pandemic levels by global health experts, is in more than 100 countries and is continuing to spread.
Last week, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, had shared that clinical trials on a first candidate vaccine were expected to begin in August.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
